Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ANS03 |
Synonyms | |
Therapy Description |
ANS03 is a type II ROS1/NTRK inhibitor with activity against ROS1 and NTRK drug resistance mutations, which potentially inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 828). |